Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT02006485 |
| Title | Ublituximab in Combination With TGR-1202 in Patients With B-cell Malignancies |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | TG Therapeutics, Inc. |
| Indications | |
| Therapies | |
| Age Groups: | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| TG Therapeutics Investigational Trial Site | Huntsville | Alabama | 35805 | United States | Details | |
| TG Therapeutics Investigational Trial Site | Jonesboro | Arkansas | 72401 | United States | Details | |
| TG Therapeutics Investigational Trial Site | Duarte | California | 91010 | United States | Details | |
| TG Therapeutics Investigational Trial Site | Atlanta | Georgia | 30322 | United States | Details | |
| TG Therapeutics Investigational Trial Site | Omaha | Nebraska | 68198 | United States | Details | |
| MD Anderson Cancer Center | Houston | Texas | 77030 | United States | Details |